P551: A PHASE 3, RANDOMIZED, OPEN-LABEL STUDY EVALUATING THE SAFETY AND EFFICACY OF MAGROLIMAB IN COMBINATION WITH AZACITIDINE IN PREVIOUSLY UNTREATED PATIENTS WITH TP53-MUTANT ACUTE MYELOID LEUKEMIA
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000845092.62208.b7 |
| _version_ | 1797287932253437952 |
|---|---|
| author | N. G. Daver P. Vyas M. P. Chao G. Xing C. Renard G. Ramsingh D. A. Sallman A. H. Wei |
| author_facet | N. G. Daver P. Vyas M. P. Chao G. Xing C. Renard G. Ramsingh D. A. Sallman A. H. Wei |
| author_sort | N. G. Daver |
| collection | DOAJ |
| first_indexed | 2024-03-07T18:41:57Z |
| format | Article |
| id | doaj.art-d7f4b915802d46b592cb2753b77d902d |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T18:41:57Z |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-d7f4b915802d46b592cb2753b77d902d2024-03-02T03:51:51ZengWileyHemaSphere2572-92412022-06-01645045110.1097/01.HS9.0000845092.62208.b7202206003-00450P551: A PHASE 3, RANDOMIZED, OPEN-LABEL STUDY EVALUATING THE SAFETY AND EFFICACY OF MAGROLIMAB IN COMBINATION WITH AZACITIDINE IN PREVIOUSLY UNTREATED PATIENTS WITH TP53-MUTANT ACUTE MYELOID LEUKEMIAN. G. Daver0P. Vyas1M. P. Chao2G. Xing3C. Renard4G. Ramsingh5D. A. Sallman6A. H. Wei71 The University of Texas MD Anderson Cancer Center, Houston, United States of America2 Weatherall Institute of Molecular Medicine, MRC Molecular Hematology Unit, University of Oxford, Oxford, United Kingdom3 Gilead Sciences, Inc., Foster City3 Gilead Sciences, Inc., Foster City3 Gilead Sciences, Inc., Foster City3 Gilead Sciences, Inc., Foster City4 Moffitt Cancer Center, Tampa, United States of America5 Department of Haematology, Alfred Hospital and Monash University, Melbourne, Australiahttp://journals.lww.com/10.1097/01.HS9.0000845092.62208.b7 |
| spellingShingle | N. G. Daver P. Vyas M. P. Chao G. Xing C. Renard G. Ramsingh D. A. Sallman A. H. Wei P551: A PHASE 3, RANDOMIZED, OPEN-LABEL STUDY EVALUATING THE SAFETY AND EFFICACY OF MAGROLIMAB IN COMBINATION WITH AZACITIDINE IN PREVIOUSLY UNTREATED PATIENTS WITH TP53-MUTANT ACUTE MYELOID LEUKEMIA HemaSphere |
| title | P551: A PHASE 3, RANDOMIZED, OPEN-LABEL STUDY EVALUATING THE SAFETY AND EFFICACY OF MAGROLIMAB IN COMBINATION WITH AZACITIDINE IN PREVIOUSLY UNTREATED PATIENTS WITH TP53-MUTANT ACUTE MYELOID LEUKEMIA |
| title_full | P551: A PHASE 3, RANDOMIZED, OPEN-LABEL STUDY EVALUATING THE SAFETY AND EFFICACY OF MAGROLIMAB IN COMBINATION WITH AZACITIDINE IN PREVIOUSLY UNTREATED PATIENTS WITH TP53-MUTANT ACUTE MYELOID LEUKEMIA |
| title_fullStr | P551: A PHASE 3, RANDOMIZED, OPEN-LABEL STUDY EVALUATING THE SAFETY AND EFFICACY OF MAGROLIMAB IN COMBINATION WITH AZACITIDINE IN PREVIOUSLY UNTREATED PATIENTS WITH TP53-MUTANT ACUTE MYELOID LEUKEMIA |
| title_full_unstemmed | P551: A PHASE 3, RANDOMIZED, OPEN-LABEL STUDY EVALUATING THE SAFETY AND EFFICACY OF MAGROLIMAB IN COMBINATION WITH AZACITIDINE IN PREVIOUSLY UNTREATED PATIENTS WITH TP53-MUTANT ACUTE MYELOID LEUKEMIA |
| title_short | P551: A PHASE 3, RANDOMIZED, OPEN-LABEL STUDY EVALUATING THE SAFETY AND EFFICACY OF MAGROLIMAB IN COMBINATION WITH AZACITIDINE IN PREVIOUSLY UNTREATED PATIENTS WITH TP53-MUTANT ACUTE MYELOID LEUKEMIA |
| title_sort | p551 a phase 3 randomized open label study evaluating the safety and efficacy of magrolimab in combination with azacitidine in previously untreated patients with tp53 mutant acute myeloid leukemia |
| url | http://journals.lww.com/10.1097/01.HS9.0000845092.62208.b7 |
| work_keys_str_mv | AT ngdaver p551aphase3randomizedopenlabelstudyevaluatingthesafetyandefficacyofmagrolimabincombinationwithazacitidineinpreviouslyuntreatedpatientswithtp53mutantacutemyeloidleukemia AT pvyas p551aphase3randomizedopenlabelstudyevaluatingthesafetyandefficacyofmagrolimabincombinationwithazacitidineinpreviouslyuntreatedpatientswithtp53mutantacutemyeloidleukemia AT mpchao p551aphase3randomizedopenlabelstudyevaluatingthesafetyandefficacyofmagrolimabincombinationwithazacitidineinpreviouslyuntreatedpatientswithtp53mutantacutemyeloidleukemia AT gxing p551aphase3randomizedopenlabelstudyevaluatingthesafetyandefficacyofmagrolimabincombinationwithazacitidineinpreviouslyuntreatedpatientswithtp53mutantacutemyeloidleukemia AT crenard p551aphase3randomizedopenlabelstudyevaluatingthesafetyandefficacyofmagrolimabincombinationwithazacitidineinpreviouslyuntreatedpatientswithtp53mutantacutemyeloidleukemia AT gramsingh p551aphase3randomizedopenlabelstudyevaluatingthesafetyandefficacyofmagrolimabincombinationwithazacitidineinpreviouslyuntreatedpatientswithtp53mutantacutemyeloidleukemia AT dasallman p551aphase3randomizedopenlabelstudyevaluatingthesafetyandefficacyofmagrolimabincombinationwithazacitidineinpreviouslyuntreatedpatientswithtp53mutantacutemyeloidleukemia AT ahwei p551aphase3randomizedopenlabelstudyevaluatingthesafetyandefficacyofmagrolimabincombinationwithazacitidineinpreviouslyuntreatedpatientswithtp53mutantacutemyeloidleukemia |